https://medicine.ouhsc.edu/Academic-Departments Parent Page: Academic Departments id: 22555 Active Page: Facultyid:23541

Faculty

Internal Medicine

Javid Fazili, MD

Professor of Medicine
Director, Liver Clinic (VA)


COMD 7400
800 Stanton L Young Blvd
Oklahoma City, OK

405-271-5428 (Office)

Javid-Fazili@ouhsc.edu


Dr. Fazili is a board-certified gastroenterologist and professor at the OU College of Medicine. He has a special interest in hepatology and liver transplantation. Fazili completed a fellowship at Albert Einstein Medical Center, Thomas Jefferson University Hospital. He completed a residency at the University Institute of Medical Sciences, Nassau County Medical Center and earned his medical degree from the University of Kashmir.


Academic Section(s):

Digestive Diseases


Education:

Kashmir University, Srinagar
MD (1985)


Board Certification(s):

American Board of Internal Medicine (1997)

Gastroenterology (2010)

Transplant Hepatology (2010)

Diplomat ECFMG (1994)


Residency:

State University of New York at Stony Brook
Internal Medicine (1997)


Fellowship:

Albert Einstein Medical Center, Philadelphia
Gastroenterology
(2000)

 
Thomas Jefferson University Hospital, Philadelphia
Hepatology/Liver Transplantation
(2001)
 


Clinical/Research Interests:

  • Hepatology (including all liver diseases, Hepatitis C & B)
  • Transplant hepatology
  • General GI (Colonoscopy, upper GI)


Funding:

Affiliation Agreements

Fazili, J. (Site PI), "Rs738409 Genotype Association of Liver Mortality after Sofosbuvir treatment," Sponsored by KUMC
Additional Information: IRB# 0695
2015 - 2018

Grants

Ding, K. (Faculty), Fazili, J. (Faculty ), Ali, N. (Faculty ), Qu, D. (Faculty), Dieckgraefe, B. (Co-Investigator), Bishnupuri, K. (Faculty ), "Circulating Biomarkers for the Detection of Human Liver Diseases," Sponsored by Oklahoma City VA Medical Center, Federal Grant/Contract Number: 1IO1CX001686-01
Total Direct Costs: $150,000.00
April 1, 2018 - March 31, 2022


Houchen, C. W. (Principal Investigator), Qu, D. (Faculty ), Sureban, S. (Faculty), Fazili, J. (Faculty), Ding, K. (Faculty), "DCLK1 is a Novel Molecular Target in Hepatocellular Carcinoma," Sponsored by Oklahoma City VA Medical Center, Federal Grant/Contract Number: 1I01BX004131-01
Total Direct Costs: $147,000.00
October 1, 2017 - September 30, 2021


Select Honors & Accomplishments:

  • Castle Connolly Medical Ltd. "Top Doctors", 2016-2020
  • Oklahoma Magazine Top Doctors (Received), 2019
  • 2019 Top Doctor, Castle Connolly (Received), February 7, 2019
  • America's Most Honored Professionals (Received), 2018
  • Oklahoma Top Doctor, 2012-2014, 2018
  • Oklahoma Super Doctors, 2015-2016
  • American College of Physicians Fellow, 2015
  • Fellow, American Association for the Study of Liver Diseases, 2015
  • Annual Overall Teaching Award for Excellence and Dedication, Digestive Diseases and Nutrtion, 2013
  • America's Top Gastroenterologist, Consumer's Research Council of American, 2012
  • US News & World Report list of top doctors, 2011
  • Advanced Hepatology Fellowship, American Association for the Study of Liver Diseases (Received), 2000
  • UNOS Qualified, United Network of Organ Sharing, 1999
  • Outstanding residents of the year, Nassau County Medical Center, State University of New York,
    Stony Brook (Nominated), 1996
  • Intern of the month, Nassau County Medical Center, State University of New York, Stony Brook, July 1995


Select Publications:

Research Networking Profile

Yohannan, B.*, Hayat, M.*#, Syed, T. A.#, Hayat, M. H.#, Hughes, D.#, Fazili, J.# (2020). Severe  Hyperbilirubinemia as a Side Effect of Three-Week Treatment with Glecaprevir/Pibrentasvir Resulting in Sustained Virologic Response. Gastroenterology, Hepatology & Digestive Disorders, 3(1), 1-2.

Syed, T., Bashir, M., Farooqui, S., Chen, S., Nusrat, S., Chen, A., Fazili, J. (2019). Treatment outcomes of Hepatitis C treated patients in specialty clinic vs. Primary Care Physician Clinic - A comparative analysis. Gastroenterology Research and Practice, 2019. DOI:10.1155/2019/8434602

Syed, T. A.*, Fazili, J., Ali, I. A.*, Zhao, D., Hughes, D., Mahmood, S.* (2018). Hepatocellular Carcinoma Occurrence and Recurrence in Hepatitis C-infected Patients Treated with Direct-acting Antivirals. Cureus, 10(6), e2843. DOI: 10.7759/cureus.2843

Bashir, M. H., Fazili, J., Madhoun, M. F., Kanagala, R., Chen, S., Nusrat, S. (2018). Impact of Sustained Virologic Response on Short-Term Clinical Outcomes in Hepatitis C-Related Cirrhosis.  European Journal of Gastroenterology & Hepatology, 30(3), 296-301. PMID: 29200006. DOI:10.1097/MEG.0000000000001032

Syed, T., Salem, G., Fazili, J. (2018). Spontaneous Intramural Esophageal Hematoma. Clin Gastroenterol Hepatol, 16(2), e19-e20. PMID: 28442317. DOI: 10.1016/j.cgh.2017.04.027

Syed, T. A.*, Mahmood, S.*, Fazili, J. (2017). Rectal Mucosal Schwann-Cell Hamartoma: A Case Report and Literature Review. Journal of Gastroenterology, Pancreatology & Liver Disorders, 5(2), 1-3. DOI: 10.15226/2374-815x/5/2/001115

Salem, G. A., Fazili, J., Ali, T. (2017). Gastric heterotopia in the rectum. A rare cause of ectopic gastric tissue. Arab J Gastroenterol, 18(1), 42-43. PMID: 28223104. DOI:10.1016/j.ajg.2017.01.005